{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:08:28Z","timestamp":1793214508634,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10572-6","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T04:00:50Z","timestamp":1747886450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mapping the complexity of multiple sclerosis: a novel perspective on genetic, environmental, and neurobiological insights"],"prefix":"10.1007","volume":"52","author":[{"given":"Ameneh","family":"Omidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Zolfaghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Mohammadhadi","family":"Mirab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maedeh Hasanzadeh","family":"Bafghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Safdari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kobra","family":"Shirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"10572_CR1","first-page":"431","volume":"283","author":"Boullerne AIJEn","year":"2016","unstructured":"Boullerne AIJEn (2016) The history of Myelin. J Hist Neurosci 283:431\u2013445","journal-title":"J Hist Neurosci"},{"issue":"2","key":"10572_CR2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/dneu.22518","volume":"78","author":"ME Bechler","year":"2018","unstructured":"Bechler ME, Swire M, Ffrench-Constant C (2018) Intrinsic and adaptive myelination: A sequential mechanism for smart wiring in the brain. Dev Neurobiol 78(2):68\u201379","journal-title":"Dev Neurobiol"},{"issue":"5","key":"10572_CR3","first-page":"343","volume":"49","author":"J Jacak","year":"2020","unstructured":"Jacak J, Jacak WJEBJ (2020) New wave-type mechanism of saltatory conduction in myelinated axons and micro-saltatory conduction in C fibres. J Electrophysiol Biol J 49(5):343\u2013360","journal-title":"J Electrophysiol Biol J"},{"issue":"11","key":"10572_CR4","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/glia.23665","volume":"67","author":"D Suminaite","year":"2019","unstructured":"Suminaite D, Lyons DA, Livesey MR (2019) Myelinated axon physiology and regulation of neural circuit function. Glia 67(11):2050\u20132062","journal-title":"Glia"},{"issue":"1","key":"10572_CR5","first-page":"61","volume":"41","author":"Monje MJAron","year":"2018","unstructured":"Monje MJAron (2018) Myelin plasticity and nervous system function. J Neurobiol 41(1):61\u201376","journal-title":"J Neurobiol"},{"issue":"10","key":"10572_CR6","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1093\/brain\/awab241","volume":"144","author":"S Bittner","year":"2021","unstructured":"Bittner S, Oh J, Havrdov\u00e1 EK, Tintor\u00e9 M, Zipp F (2021) The potential of serum neurofilament as a biomarker for multiple sclerosis. Brain 144(10):2954\u20132963","journal-title":"Brain"},{"key":"10572_CR7","first-page":"600656","volume":"14","author":"BP Morgan","year":"2021","unstructured":"Morgan BP, Gommerman JL, Ramaglia VJFCN (2021) An outside-in and inside-out consideration of complement in the multiple sclerosis brain: lessons from development and neurodegenerative diseases. Front Immunol 14:600656","journal-title":"Front Immunol"},{"key":"10572_CR8","doi-asserted-by":"crossref","unstructured":"Luchicchi A, Preziosa P, \u2018t Hart B (2021) Editorial: Inside-Out vs Outside-In paradigms in multiple sclerosis etiopathogenesis. Front Immunol 15","DOI":"10.3389\/fncel.2021.666529"},{"key":"10572_CR9","doi-asserted-by":"crossref","unstructured":"Profaci CP, Munji RN, Pulido RS, Daneman RJJEM (2020) The blood\u2013brain barrier in health and disease: important unanswered questions. J Exp Med 217(4)","DOI":"10.1084\/jem.20190062"},{"issue":"1151","key":"10572_CR10","first-page":"20230016","volume":"96","author":"DJ Wang","year":"2023","unstructured":"Wang DJ, Hua J, Cao D, Ho M-LJTB (2023) Neurofluids and the glymphatic system: anatomy, physiology, and imaging. J Biomed Imaging 96(1151):20230016","journal-title":"J Biomed Imaging"},{"issue":"3","key":"10572_CR11","doi-asserted-by":"crossref","first-page":"fcad134","DOI":"10.1093\/braincomms\/fcad134","volume":"5","author":"T Butler","year":"2023","unstructured":"Butler T, Zhou L, Ozsahin I, Wang XH, Garetti J, Zetterberg H et al (2023) Glymphatic clearance estimated using diffusion tensor imaging along perivascular spaces is reduced after traumatic brain injury and correlates with plasma neurofilament light, a biomarker of injury severity. Brain Commun 5(3):fcad134","journal-title":"Brain Commun"},{"key":"10572_CR12","doi-asserted-by":"crossref","unstructured":"Nishihara H, Engelhardt B (2020) Brain barriers and multiple sclerosis: novel treatment approaches from a brain barriers perspective. Physiology, Pharmacology and pathology of the Blood-Brain barrier. Springer, pp 295\u2013329","DOI":"10.1007\/164_2020_407"},{"issue":"8","key":"10572_CR13","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1177\/0271678X221098145","volume":"42","author":"G Li","year":"2022","unstructured":"Li G, Cao Y, Tang X, Huang J, Cai L, Zhou L (2022) The meningeal lymphatic vessels and the glymphatic system: potential therapeutic targets in neurological disorders. J Cereb Blood Flow Metab 42(8):1364\u20131382","journal-title":"J Cereb Blood Flow Metab"},{"key":"10572_CR14","first-page":"105437","volume":"83","author":"Y Tomizawa","year":"2024","unstructured":"Tomizawa Y, Hagiwara A, Hoshino Y, Nakaya M, Kamagata K, Cossu D et al (2024) The glymphatic system as a potential biomarker and therapeutic target in secondary progressive multiple sclerosis. J Neurol 83:105437","journal-title":"J Neurol"},{"key":"10572_CR15","doi-asserted-by":"crossref","unstructured":"Garg N, Reddel S, Miller D, Chataway J, Riminton D, Barnett Y et al (2015) The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases. J Neurol Neurosurg Psychiatry 86","DOI":"10.1136\/jnnp-2014-309649"},{"issue":"2","key":"10572_CR16","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3390\/cimb45020094","volume":"45","author":"G Papiri","year":"2023","unstructured":"Papiri G, D\u2019Andreamatteo G, Cacchi\u00f2 G, Alia S, Silvestrini M, Paci C et al (2023) Multiple sclerosis: inflammatory and neuroglial aspects. Curr Issues Mol Biol 45(2):1443\u20131470","journal-title":"Curr Issues Mol Biol"},{"issue":"16","key":"10572_CR17","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.3390\/ijms25168921","volume":"25","author":"I Manna","year":"2024","unstructured":"Manna I, De Benedittis S, Porro DJIJMS (2024) A comprehensive examination of the role of epigenetic factors in multiple sclerosis. J Mol Sci 25(16):8921","journal-title":"J Mol Sci"},{"issue":"16","key":"10572_CR18","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.3390\/ijms25168921","volume":"25","author":"I Manna","year":"2024","unstructured":"Manna I, De Benedittis S, Porro D (2024) A comprehensive examination of the role of epigenetic factors in multiple sclerosis. J Mol Sci 25(16):8921","journal-title":"J Mol Sci"},{"issue":"3","key":"10572_CR19","first-page":"481","volume":"6","author":"R Mechelli","year":"2010","unstructured":"Mechelli R, Annibali V, Ristori G, Vittori D, Coarelli G, Salvetti MJE (2010) Multiple sclerosis etiology: beyond genes and environment. Eur Rev Med Pharmacol Sci 6(3):481\u2013490","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1\u20132","key":"10572_CR20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneuroim.2014.08.618","volume":"276","author":"N Su","year":"2014","unstructured":"Su N, Shi SX, Zhu X, Borazanci A, Shi F-D, Gan YJJ (2014) Interleukin-7 expression and its effect on natural killer cells in patients with multiple sclerosis. J Neuroimmunol 276(1\u20132):180\u2013186","journal-title":"J Neuroimmunol"},{"issue":"19","key":"10572_CR21","doi-asserted-by":"crossref","first-page":"e3612","DOI":"10.1097\/MD.0000000000003612","volume":"95","author":"T Jiang","year":"2016","unstructured":"Jiang T, Li L, Wang Y, Zhao C, Yang J, Ma D et al (2016) The association between genetic polymorphism rs703842 in CYP27B1 and multiple sclerosis: A meta-analysis. Medicine 95(19):e3612","journal-title":"Medicine"},{"key":"10572_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-017-1697-7","volume":"134","author":"R van den Berg","year":"2017","unstructured":"van den Berg R, Hoogenraad CC, Hintzen RQJA (2017) Axonal transport deficits in multiple sclerosis: spiraling into the Abyss. Acta Neuropathol 134:1\u201314","journal-title":"Acta Neuropathol"},{"issue":"10","key":"10572_CR23","first-page":"1233","volume":"49","author":"T Fazia","year":"2019","unstructured":"Fazia T, Pastorino R, Notartomaso S, Busceti C, Imbriglio T, Cannella M et al (2019) Acid sensing ion channel 2: A new potential player in the pathophysiology of multiple sclerosis. Neurobiol Dis 49(10):1233\u20131243","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10572_CR24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10565-022-09761-x","volume":"39","author":"S Li","year":"2023","unstructured":"Li S, Lei Z, Sun T (2023) The role of MicroRNAs in neurodegenerative diseases: A review. Cell Biol Toxicol 39(1):53\u201383","journal-title":"Cell Biol Toxicol"},{"issue":"6","key":"10572_CR25","first-page":"e1018","volume":"7","author":"C Cotsapas","year":"2018","unstructured":"Cotsapas C, Mitrovic MJ, Immunology T (2018) Genome-wide association studies of multiple sclerosis. J Clin Immunol 7(6):e1018","journal-title":"J Clin Immunol"},{"issue":"3","key":"10572_CR26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/cells14030150","volume":"14","author":"F Vujovic","year":"2025","unstructured":"Vujovic F, Farahani RM (2025) Thyroid hormones and brain development: A focus on the role of mitochondria as regulators of developmental time. Cells 14(3):150","journal-title":"Cells"},{"issue":"37","key":"10572_CR27","first-page":"e39709","volume":"103","author":"W Cui","year":"2024","unstructured":"Cui W, Wang B, Shi K, Wang X, Chen S, Xu A et al (2024) Causal relationship between thyroid function and multiple sclerosis: A bidirectional Mendelian randomization study. Front Neurol 103(37):e39709","journal-title":"Front Neurol"},{"issue":"2","key":"10572_CR28","first-page":"213","volume":"19","author":"E Dalas","year":"2023","unstructured":"Dalas E, Hamad M, Taha MJAKCMJ (2023) Assessment of thyroid functions in multiple sclerosis patients treated with disease modifying therapies: thyroid functions in multiple sclerosis. Kuwait Med J 19(2):213\u2013217","journal-title":"Kuwait Med J"},{"issue":"2","key":"10572_CR29","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/sxmrev\/qead050","volume":"12","author":"MAM Hammad","year":"2024","unstructured":"Hammad MAM, Rush A, Loeb CA, Banton J, Abou Chawareb E, Khanmammadova N et al (2024) Multiple sclerosis and hypogonadism: is there a relationship? Sex Med Rev 12(2):178\u2013182","journal-title":"Sex Med Rev"},{"issue":"1","key":"10572_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-023-01326-7","volume":"24","author":"S Hsu","year":"2024","unstructured":"Hsu S, Bove R (2024) Hormonal therapies in multiple sclerosis: A review of clinical data. Curr Neurol Neurosci Rep 24(1):1\u201315","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10572_CR31","doi-asserted-by":"crossref","unstructured":"Murgia F, Giagnoni F, Lorefice L, Caria P, Dettori T, D\u2019Alterio MN et al (2022) Sex hormones as key modulators of the immune response in multiple sclerosis: A review. Biomedicines 10(12)","DOI":"10.3390\/biomedicines10123107"},{"key":"10572_CR32","doi-asserted-by":"crossref","unstructured":"Maglione A, Rolla S, Mercanti SF, Cutrupi S, Clerico M (2019) The adaptive immune system in multiple sclerosis: An estrogen-mediated point of view. Cells 8(10)","DOI":"10.3390\/cells8101280"},{"key":"10572_CR33","first-page":"38","volume":"122","author":"R Sitruk-Ware","year":"2021","unstructured":"Sitruk-Ware R, Bonsack B, Brinton R, Schumacher M, Kumar N, Lee J-Y et al (2021) Progress in progestin-based therapies for neurological disorders. Neuroscience 122:38\u201365","journal-title":"Neuroscience"},{"issue":"1","key":"10572_CR34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000525677","volume":"113","author":"TB Bassani","year":"2023","unstructured":"Bassani TB, Bartolomeo CS, Oliveira RB, Ureshino RP (2023) Progestogen-mediated neuroprotection in central nervous system disorders. Neuroendocrinology 113(1):14\u201335","journal-title":"Neuroendocrinology"},{"issue":"12","key":"10572_CR35","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.3390\/ijms17122026","volume":"17","author":"M Costanza","year":"2016","unstructured":"Costanza M, Pedotti RJI (2016) Prolactin: friend or foe in central nervous system autoimmune inflammation? Int J Mol Sci 17(12):2026","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10572_CR36","first-page":"323","volume":"32","author":"E Ramos-Martinez","year":"2021","unstructured":"Ramos-Martinez E, Ramos-Mart\u00ednez I, Molina-Salinas G, Zepeda-Ruiz WA, Cerbon MJRN (2021) The role of prolactin in central nervous system inflammation. Rev Inv Clin 32(3):323\u2013340","journal-title":"Rev Inv Clin"},{"issue":"2","key":"10572_CR37","first-page":"482","volume":"9","author":"M Kunkl","year":"2020","unstructured":"Kunkl M, Frascolla S, Amormino C, Volpe E, Tuosto L (2020) T helper cells: the modulators of inflammation in multiple sclerosis. Front Immunol 9(2):482","journal-title":"Front Immunol"},{"key":"10572_CR38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuroscience.2024.04.004","volume":"548","author":"Z Khan","year":"2024","unstructured":"Khan Z, Mehan S, Gupta GD, Narula AS (2024) Immune system dysregulation in the progression of multiple sclerosis: molecular insights and therapeutic implications. Neuroscience 548:9\u201326","journal-title":"Neuroscience"},{"key":"10572_CR39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clim.2017.07.020","volume":"186","author":"S Fillatreau","year":"2018","unstructured":"Fillatreau S (2018) B cells and their cytokine activities implications in human diseases. Clin Immunol 186:26\u201331","journal-title":"Clin Immunol"},{"key":"10572_CR40","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3389\/fimmu.2019.01140","volume":"10","author":"WT Ma","year":"2019","unstructured":"Ma WT, Gao F, Gu K, Chen DK (2019) The role of monocytes and macrophages in autoimmune diseases: A comprehensive review. Front Immunol 10:1140","journal-title":"Front Immunol"},{"issue":"1","key":"10572_CR41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(22)00184-3","volume":"22","author":"JS Graves","year":"2023","unstructured":"Graves JS, Krysko KM, Hua LH, Absinta M, Franklin RJM, Segal BM (2023) Ageing and multiple sclerosis. Lancet Neurol 22(1):66\u201377","journal-title":"Lancet Neurol"},{"key":"10572_CR42","doi-asserted-by":"crossref","first-page":"1412482","DOI":"10.3389\/fgwh.2024.1412482","volume":"5","author":"N Nathoo","year":"2024","unstructured":"Nathoo N, Neyal N, Kantarci OH, Zeydan B (2024) Imaging phenotypic differences in multiple sclerosis: at the crossroads of aging, sex, race, and ethnicity. Front Glob Women Health 5:1412482","journal-title":"Front Glob Women Health"},{"issue":"6","key":"10572_CR43","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/eji.202149757","volume":"52","author":"B Engelhardt","year":"2022","unstructured":"Engelhardt B, Comabella M, Chan A (2022) Multiple sclerosis: immunopathological heterogeneity and its implications. Eur J Immunol 52(6):869\u2013881","journal-title":"Eur J Immunol"},{"key":"10572_CR44","doi-asserted-by":"crossref","first-page":"1197212","DOI":"10.3389\/fneur.2023.1197212","volume":"14","author":"G Macaron","year":"2023","unstructured":"Macaron G, Larochelle C, Arbour N, Galmard M, Girard JM, Prat A et al (2023) Impact of aging on treatment considerations for multiple sclerosis patients. Front Neurol 14:1197212","journal-title":"Front Neurol"},{"key":"10572_CR45","doi-asserted-by":"crossref","first-page":"106","DOI":"10.15698\/mic2024.04.819","volume":"11","author":"AC Paraschiv","year":"2024","unstructured":"Paraschiv AC, Vacaras V, Nistor C, Vacaras C, Strilciuc S, Muresanu DF (2024) The effect of multiple sclerosis therapy on gut microbiota dysbiosis: A longitudinal prospective study. Microb Cell (Graz Austria) 11:106\u2013115","journal-title":"Microb Cell (Graz Austria)"},{"issue":"13","key":"10572_CR46","first-page":"1760","volume":"12","author":"A Dunalska","year":"2023","unstructured":"Dunalska A, Saramak K, Szejko NJC (2023) The role of gut Microbiome in the pathogenesis of multiple sclerosis and related disorders. J Clin 12(13):1760","journal-title":"J Clin"},{"issue":"1","key":"10572_CR47","first-page":"15","volume":"80","author":"S Sedighi","year":"2023","unstructured":"Sedighi S, Gholizadeh O, Yasamineh S, Akbarzadeh S, Amini P, Favakehi P et al (2023) Comprehensive investigations relationship between viral infections and multiple sclerosis pathogenesis. Infect Dis 80(1):15","journal-title":"Infect Dis"},{"key":"10572_CR48","doi-asserted-by":"crossref","first-page":"1212676","DOI":"10.3389\/fimmu.2023.1212676","volume":"14","author":"AK Hedstr\u00f6m","year":"2023","unstructured":"Hedstr\u00f6m AK (2023) Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection. Front Immunol 14:1212676","journal-title":"Front Immunol"},{"issue":"1","key":"10572_CR49","first-page":"51","volume":"21","author":"SS Soldan","year":"2023","unstructured":"Soldan SS, Lieberman PMJNRM (2023) Epstein\u2013Barr virus and multiple sclerosis. J Neurol Res Manag 21(1):51\u201364","journal-title":"J Neurol Res Manag"},{"issue":"1","key":"10572_CR50","first-page":"30","volume":"29","author":"J-H Ng","year":"2023","unstructured":"Ng J-H, Sun A, Je HS, Tan E-K (2023) Unraveling pathophysiology of neurological and psychiatric complications of COVID-19 using brain organoids. J Transl Neurosci 29(1):30\u201340","journal-title":"J Transl Neurosci"},{"issue":"10","key":"10572_CR51","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3390\/v13102091","volume":"13","author":"NJ Satheesh","year":"2021","unstructured":"Satheesh NJ, Salloum-Asfar S, Abdulla SAJV (2021) The potential role of COVID-19 in the pathogenesis of multiple sclerosis\u2014a preliminary report. J Virus 13(10):2091","journal-title":"J Virus"},{"key":"10572_CR52","doi-asserted-by":"crossref","first-page":"755333","DOI":"10.3389\/fimmu.2021.755333","volume":"12","author":"G Bellucci","year":"2021","unstructured":"Bellucci G, Rinaldi V, Buscarinu MC, Reni\u00e8 R, Bigi R, Pellicciari G et al (2021) Multiple sclerosis and SARS-CoV-2: has the interplay started? Front Immunol 12:755333","journal-title":"Front Immunol"},{"issue":"4","key":"10572_CR53","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00415-020-10131-y","volume":"268","author":"T Schirinzi","year":"2021","unstructured":"Schirinzi T, Landi D, Liguori CJJ (2021) COVID-19: dealing with a potential risk factor for chronic neurological disorders. J Neural Transm 268(4):1171\u20131178","journal-title":"J Neural Transm"},{"issue":"6","key":"10572_CR54","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00002060-199511000-00004","volume":"74","author":"NS Rapp","year":"1995","unstructured":"Rapp NS, Gilroy J, Lerner AMA, Rehabilitation (1995) Role of bacterial infection in exacerbation of multiple sclerosis. Am J Phys Med Rehabil 74(6):415\u2013418","journal-title":"Am J Phys Med Rehabil"},{"key":"10572_CR55","doi-asserted-by":"crossref","unstructured":"Schwegman L, Bartsch B, Abdul-Baki N, de Oca Arena MM, Negron A, Forsthuber T (2023) Investigating molecular mimicry by microbial peptides in the induction of experimental autoimmune encephalomyelitis. J Immunol 210(Suppl 1):170.02-170.02","DOI":"10.4049\/jimmunol.210.Supp.170.02"},{"key":"10572_CR56","doi-asserted-by":"crossref","first-page":"123161","DOI":"10.1016\/j.jns.2024.123161","volume":"464","author":"R Gouider","year":"2024","unstructured":"Gouider R, Souissi A, Mrabet S, Gharbi A, Abida Y, Kacem I et al (2024) Environmental factors related to multiple sclerosis progression. J Neurol Sci 464:123161","journal-title":"J Neurol Sci"},{"issue":"8","key":"10572_CR57","doi-asserted-by":"crossref","first-page":"e0221645","DOI":"10.1371\/journal.pone.0221645","volume":"14","author":"K Ismailova","year":"2019","unstructured":"Ismailova K, Poudel P, Parlesak A, Frederiksen P, Heitmann BL (2019) Vitamin D in early life and later risk of multiple sclerosis: A systematic review and meta-analysis. PLoS ONE 14(8):e0221645","journal-title":"PLoS ONE"},{"issue":"19","key":"10572_CR58","first-page":"2391","volume":"12","author":"C Carlberg","year":"2023","unstructured":"Carlberg C, Mycko MPJC (2023) Linking mechanisms of vitamin D signaling with multiple sclerosis. J Clin 12(19):2391","journal-title":"J Clin"},{"issue":"4","key":"10572_CR59","doi-asserted-by":"crossref","first-page":"152","DOI":"10.7224\/1537-2073.2022-032","volume":"25","author":"SL Hsieh","year":"2023","unstructured":"Hsieh SL, Shultz JM, Briggs F, Espinel Z, Shapiro LT (2023) Climate change and the urgent need to prepare persons with multiple sclerosis for extreme hurricanes. Int J MS Care 25(4):152\u2013156","journal-title":"Int J MS Care"},{"issue":"1","key":"10572_CR60","first-page":"45","volume":"3","author":"S-A Tabatabaei","year":"2022","unstructured":"Tabatabaei S-A, Ariafar S, Mohammadi MJAJPR (2022) Toxic environmental factors and multiple sclerosis: A mechanistic view. J Psychol Res 3(1):45\u201354","journal-title":"J Psychol Res"},{"key":"10572_CR61","doi-asserted-by":"crossref","unstructured":"Ortiz GG, Pacheco-Mois\u00e9s FP, Bitzer-Quintero OK, Ram\u00edrez-Anguiano AC, Flores-Alvarado LJ, Ram\u00edrez-Ram\u00edrez V et al (2013) Immunology and oxidative stress in multiple sclerosis: Clinical and basic approaches. Clin Dev Immunol 2013:708659","DOI":"10.1155\/2013\/708659"},{"issue":"8","key":"10572_CR62","first-page":"e66754","volume":"16","author":"C Ke\u00e7ecio\u011flu","year":"2024","unstructured":"Ke\u00e7ecio\u011flu C, Sar\u0131kaya C, Ayd\u0131n A, Charehsaz M, Efendi H (2024) Investigation of the relationship between heavy metals (cadmium, arsenic, and lead) and Metallothionein in multiple sclerosis. Cureus 16(8):e66754","journal-title":"Cureus"},{"key":"10572_CR63","doi-asserted-by":"crossref","unstructured":"Nehzomi ZS, Shirani K (2024) Investigating the role of food pollutants in autism spectrum disorder: A comprehensive analysis of heavy metals, pesticides, and Mycotoxins. Naunyn-Schmiedeberg\u2019s Arch Pharmacol","DOI":"10.1007\/s00210-024-03551-4"},{"issue":"8","key":"10572_CR64","first-page":"e66754","volume":"16","author":"C Ke\u00e7ecio\u011flu","year":"2024","unstructured":"Ke\u00e7ecio\u011flu C, Sar\u0131kaya C, Ayd\u0131n A, Charehsaz M, Efendi HJC (2024) Investigation of the relationship between heavy metals (cadmium, arsenic, and lead) and Metallothionein in multiple sclerosis. Cureus 16(8):e66754","journal-title":"Cureus"},{"issue":"3","key":"10572_CR65","first-page":"249","volume":"9","author":"K Shirani","year":"2017","unstructured":"Shirani K, Shahbazi N, Khayat MH, Khashayarmanesh Z, Hassani FV, Moharerri N et al (2017) Concentration of heavy metals in Iranian market rice and associated population health risk. J Environ Health Sci Eng 9(3):249\u2013254","journal-title":"J Environ Health Sci Eng"},{"issue":"2","key":"10572_CR66","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00420-020-01564-z","volume":"94","author":"L Gerhardsson","year":"2021","unstructured":"Gerhardsson L, Hou L, Pettersson K (2021) Work-related exposure to organic solvents and the risk for multiple sclerosis: A systematic review. Int Arch Occup Environ Health 94(2):221\u2013229","journal-title":"Int Arch Occup Environ Health"},{"key":"10572_CR67","doi-asserted-by":"crossref","first-page":"1285103","DOI":"10.3389\/fpubh.2023.1285103","volume":"11","author":"BK Vitturi","year":"2023","unstructured":"Vitturi BK, Montecucco A, Rahmani A, Dini G, Durando P (2023) Occupational risk factors for multiple sclerosis: A systematic review with meta-analysis. Front Public Health 11:1285103","journal-title":"Front Public Health"},{"issue":"3","key":"10572_CR68","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.taap.2011.05.006","volume":"256","author":"T Parr\u00f3n","year":"2011","unstructured":"Parr\u00f3n T, Requena M, Hern\u00e1ndez AF, Alarc\u00f3n R (2011) Association between environmental exposure to pesticides and neurodegenerative diseases. Toxicol Appl Pharmacol 256(3):379\u2013385","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1\u20132","key":"10572_CR69","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.brainresbull.2010.02.012","volume":"82","author":"CB Purzycki","year":"2010","unstructured":"Purzycki CB, Shain DH (2010) Fungal toxins and multiple sclerosis: A compelling connection. Brain Res Bull 82(1\u20132):4\u20136","journal-title":"Brain Res Bull"},{"key":"10572_CR70","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fneur.2017.00535","volume":"8","author":"J Benito-Le\u00f3n","year":"2017","unstructured":"Benito-Le\u00f3n J, Laurence M (2017) The role of fungi in the etiology of multiple sclerosis. Front Neurol 8:535","journal-title":"Front Neurol"},{"key":"10572_CR71","doi-asserted-by":"crossref","first-page":"110386","DOI":"10.1016\/j.envres.2020.110386","volume":"196","author":"Z Noorimotlagh","year":"2021","unstructured":"Noorimotlagh Z, Azizi M, Pan H-F, Mami S, Mirzaee SA (2021) Association between air pollution and multiple sclerosis: A systematic review. Environ Res 196:110386","journal-title":"Environ Res"},{"key":"10572_CR72","doi-asserted-by":"crossref","unstructured":"Chuang T-y, Feldman T, Healy B, Saxena S, Sanon E, Saraceno T et al (2023) Effect of endocrine disrupting chemicals on early disease course in multiple sclerosis (P5-3.004). Neurology 100(17_Supplement_2):2496","DOI":"10.1212\/WNL.0000000000202598"},{"key":"10572_CR73","first-page":"51","volume":"83","author":"V Naffaa","year":"2021","unstructured":"Naffaa V, Lapr\u00e9vote O, Schang A-LJN (2021) Effects of endocrine disrupting chemicals on Myelin development and diseases. J Neurochem 83:51\u201368","journal-title":"J Neurochem"},{"issue":"7","key":"10572_CR74","first-page":"518","volume":"94","author":"Z Nasr","year":"2023","unstructured":"Nasr Z, Schoeps VA, Ziaei A, Virupakshaiah A, Adams C, Casper TC et al (2023) Gene\u2013environment interactions increase the risk of pediatric-onset multiple sclerosis associated with household chemical exposures. Neurology 94(7):518\u2013525","journal-title":"Neurology"},{"issue":"18","key":"10572_CR75","first-page":"3100","volume":"16","author":"M Mallardo","year":"2024","unstructured":"Mallardo M, Mazzeo F, Lus G, Signoriello E, Daniele A, Nigro E (2024) Impact of lifestyle interventions on multiple sclerosis: focus on adipose tissue. Biomedicines 16(18):3100","journal-title":"Biomedicines"},{"key":"10572_CR76","doi-asserted-by":"crossref","unstructured":"Khattab R, Goja A, AlAmmar W (2024) Effect of diet and dietary patterns on the progression of multiple sclerosis: A review. Recent Adv Food Nutr Agric","DOI":"10.2174\/012772574X325602240910075218"},{"issue":"4","key":"10572_CR77","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s40120-023-00505-5","volume":"12","author":"L Skovgaard","year":"2023","unstructured":"Skovgaard L, Tr\u00e9nel P, Westergaard K, Knudsen AK (2023) Dietary patterns and their associations with symptom levels among people with multiple sclerosis: A real-world digital study. Neurol Ther 12(4):1335\u20131357","journal-title":"Neurol Ther"},{"issue":"23","key":"10572_CR78","first-page":"e2253","volume":"97","author":"RAA H\u00f8glund","year":"2021","unstructured":"H\u00f8glund RAA, Meyer HE, Stigum H, Torkildsen \u00d8, Grytten N, Holm\u00f8y T et al (2021) Association of body mass index in adolescence and young adulthood and long-term risk of multiple sclerosis: A population-based study. Neurology 97(23):e2253\u2013e2261","journal-title":"Neurology"},{"key":"10572_CR79","doi-asserted-by":"crossref","first-page":"104647","DOI":"10.1016\/j.ebiom.2023.104647","volume":"93","author":"R Zeng","year":"2023","unstructured":"Zeng R, Jiang R, Huang W, Wang J, Zhang L, Ma Y et al (2023) Dissecting shared genetic architecture between obesity and multiple sclerosis. EBioMedicine 93:104647","journal-title":"EBioMedicine"},{"issue":"1","key":"10572_CR80","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/jnnp-2022-329685","volume":"94","author":"I Lutfullin","year":"2023","unstructured":"Lutfullin I, Eveslage M, Bittner S, Antony G, Flaskamp M, Luessi F et al (2023) Association of obesity with disease outcome in multiple sclerosis. J Neurol Neurosurg Psychiatry 94(1):57\u201361","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10572_CR81","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ana.27112","volume":"97","author":"F Alzamanan","year":"2024","unstructured":"Alzamanan F, Ding Y, Harroud A (2024) Obesity and multiple sclerosis severity: A Mendelian randomization study. Ann Neurol 97(1):90\u201394","journal-title":"Ann Neurol"},{"issue":"12","key":"10572_CR82","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2174\/1871530322666220215110041","volume":"22","author":"G Daryabor","year":"2022","unstructured":"Daryabor G, Amirghofran Z, Gholijani N, Bemani P (2022) Obesity and adipose tissue-derived cytokines in the pathogenesis of multiple sclerosis. Endocr Metab Immune Disord Drug Targets 22(12):1217\u20131231","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"4","key":"10572_CR83","first-page":"518","volume":"140","author":"H Xu","year":"2022","unstructured":"Xu H, Qiao L, Fang S, Ren Z, Wu G, Zheng Y et al (2022) Alcohol consumption is associated with excessive risk of multiple sclerosis: A meta-analysis observational study. J Clin Neurosci 140(4):518\u2013524","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10572_CR84","first-page":"31","volume":"1","author":"MJJRMS Farrokhi","year":"2021","unstructured":"Farrokhi MJJRMS (2021) Association between multiple sclerosis and alcohol consumption: one hypothesis based on immunological studies. J Res Med Sci 1(1):31\u201345","journal-title":"J Res Med Sci"},{"issue":"2","key":"10572_CR85","first-page":"58","volume":"12","author":"M Fahim","year":"2020","unstructured":"Fahim M, Rafiee Zadeh A, Shoureshi P, Ghadimi K, Cheshmavar M, Sheikhinia N et al (2020) Alcohol and multiple sclerosis: an immune system-based review. Int J Physiol Pathophysiol Pharmacol 12(2):58\u201369","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"issue":"7","key":"10572_CR86","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.amjmed.2020.03.008","volume":"133","author":"BJT Arneth","year":"2020","unstructured":"Arneth BJT (2020) Multiple sclerosis and smoking. Ann J Med 133(7):783\u2013788","journal-title":"Ann J Med"},{"issue":"2","key":"10572_CR87","first-page":"245","volume":"77","author":"M Rosso","year":"2020","unstructured":"Rosso M, Chitnis TJJ (2020) Association between cigarette smoking and multiple sclerosis: A review. J Neurol 77(2):245\u2013253","journal-title":"J Neurol"},{"key":"10572_CR88","first-page":"475","volume":"23","author":"S Saedmocheshi","year":"2024","unstructured":"Saedmocheshi S, Yousfi N, Chamari K (2024) Breaking boundaries: the transformative role of exercise in managing multiple sclerosis. EXCLI J 23:475\u2013490","journal-title":"EXCLI J"},{"issue":"10","key":"10572_CR89","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1111\/sms.14407","volume":"33","author":"S Reina-Guti\u00e9rrez","year":"2023","unstructured":"Reina-Guti\u00e9rrez S, Meseguer-Henarejos AB, Torres-Costoso A, \u00c1lvarez-Bueno C, Cavero-Redondo I, de N\u00fa\u00f1ez S et al (2023) Effect of different types of exercise on fitness in people with multiple sclerosis: A network meta-analysis. Scand J Med Sci Sports 33(10):1916\u20131928","journal-title":"Scand J Med Sci Sports"},{"issue":"7","key":"10572_CR90","first-page":"613","volume":"98","author":"Y Kim","year":"2019","unstructured":"Kim Y, Lai B, Mehta T, Thirumalai M, Padalabalanarayanan S, Rimmer JH et al (2019) Exercise training guidelines for multiple sclerosis, stroke, and Parkinson disease: rapid review and synthesis. J Phys Ther 98(7):613\u2013621","journal-title":"J Phys Ther"},{"key":"10572_CR91","first-page":"104142","volume":"67","author":"J Jiang","year":"2022","unstructured":"Jiang J, Abduljabbar S, Zhang C, Osier NJMS, Disorders R (2022) The relationship between stress and disease onset and relapse in multiple sclerosis: A systematic review. Mult Scler 67:104142","journal-title":"Mult Scler"},{"issue":"2","key":"10572_CR92","doi-asserted-by":"crossref","first-page":"205510291561227","DOI":"10.1177\/2055102915612271","volume":"2","author":"L Briones-Buixassa","year":"2015","unstructured":"Briones-Buixassa L, Mil\u00e0 R, M\u00aa Aragon\u00e8s J, Bufill E, Olaya B, Arrufat FXJH (2015) Stress and multiple sclerosis: A systematic review considering potential moderating and mediating factors and methods of assessing stress. Health Psychol Open 2(2):2055102915612271","journal-title":"Health Psychol Open"},{"issue":"3","key":"10572_CR93","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s00415-022-11497-x","volume":"270","author":"R Simpson","year":"2023","unstructured":"Simpson R, Posa S, Bruno T, Simpson S, Wasilewski MB, Robinson LR et al (2023) Conceptualization, use, and outcomes associated with compassion in the care of people with multiple sclerosis: A scoping review. J Neurol 270(3):1300\u20131322","journal-title":"J Neurol"},{"issue":"5","key":"10572_CR94","first-page":"331","volume":"94","author":"T \u00c5kerstedt","year":"2023","unstructured":"\u00c5kerstedt T, Olsson T, Alfredsson L, Hedstr\u00f6m AK (2023) Insufficient sleep during adolescence and risk of multiple sclerosis: results from a Swedish case-control study. J Neurol 94(5):331\u2013336","journal-title":"J Neurol"},{"issue":"5","key":"10572_CR95","first-page":"733","volume":"70","author":"AK Hedstr\u00f6m","year":"2011","unstructured":"Hedstr\u00f6m AK, \u00c5kerstedt T, Hillert J, Olsson T, Alfredsson L (2011) Shift work at young age is associated with increased risk for multiple sclerosis. Acta Neurol Scand 70(5):733\u2013741","journal-title":"Acta Neurol Scand"},{"key":"10572_CR96","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s40264-017-0551-0","volume":"40","author":"IC Antonazzo","year":"2017","unstructured":"Antonazzo IC, Raschi E, Vignatelli L, Baldin E, Riise T, D\u2019Alessandro R et al (2017) Occurrence of multiple sclerosis after drug exposure: insights from evidence mapping. Drug Saf 40:823\u2013834","journal-title":"Drug Saf"},{"issue":"9","key":"10572_CR97","first-page":"869","volume":"17","author":"IC Antonazzo","year":"2018","unstructured":"Antonazzo IC, Raschi E, Forcesi E, Riise T, Bjornevik K, Baldin E et al (2018) Multiple sclerosis as an adverse drug reaction: clues from the FDA adverse event reporting system. Drug Saf 17(9):869\u2013874","journal-title":"Drug Saf"},{"issue":"2","key":"10572_CR98","first-page":"133","volume":"27","author":"HY Yong","year":"2018","unstructured":"Yong HY, McKay KA, Daley CG, Tremlett HJP, Safety D (2018) Drug exposure and the risk of multiple sclerosis: A systematic review. Drug Saf 27(2):133\u2013139","journal-title":"Drug Saf"},{"issue":"6","key":"10572_CR99","first-page":"e558","volume":"100","author":"L Li","year":"2023","unstructured":"Li L, Avi\u00f1a-Zubieta JA, Bernstein CN, Kaplan GG, Tremlett H, Xie H et al (2023) Risk of multiple sclerosis among users of antitumor necrosis factor \u03b1 in 4 Canadian provinces: A population-based study. Neurology 100(6):e558\u2013e567","journal-title":"Neurology"},{"key":"10572_CR100","doi-asserted-by":"crossref","first-page":"102942","DOI":"10.1016\/j.msard.2021.102942","volume":"51","author":"J Avasarala","year":"2021","unstructured":"Avasarala J, Guduru Z, McLouth CJ, Wilburn A, Talbert J, Sutton P et al (2021) Use of anti-TNF-\u03b1 therapy in Crohn\u2019s disease is associated with increased incidence of multiple sclerosis. Mult Scler Relat Disord 51:102942","journal-title":"Mult Scler Relat Disord"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10572-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10572-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10572-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:26:02Z","timestamp":1766852762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10572-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10572"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10572-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research protocol approval by the institutional ethics committee"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"484"}}